← Leaderboards
Rodger Novak
Harvard University
$1,306,095
Attributed
$1,306,095
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $287.3K · FY2015–19$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,306,095 · 1
By mechanism
U19$1,306,095 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University
Same institution · by research overlap
- Alison Lynn Hill$2,100,701
- David A Weitz$6,736,844
- David J Mooney$45,709,587
- Alexis C. Komor$3,350,803
- Qiao Joe Zhou$8,903,376
Others in their field
Top investigators on “European”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Carol Nesel · Westat$188,148,170
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- Pavel Kabat · Internationales Institut Fur Angewandte Systemanalyse$125,737,704
- Barbara Driver · Westat, Inc.$95,724,261
Research focus
EuropeanGene-ModifiedDoseEnsureAutologous TransplantationBaseBerlinConditioningCytotoxicElementsBone Marrow TransplantationCcr5 GeneCd4 Positive T LymphocytesCell CountCellsCell TypeChemistryBiodistributionClinicClinical ApplicationClinically RelevantBlood CellsClinical TrialsGeneral Population
Grant awards (5)
Preclinical development of gene-edited human hematopoietic stem cells$208,845
U19 · FY2019 · HL · contact PI
Preclinical development of gene-edited human hematopoietic stem cells$270,000
U19 · FY2018 · HL · contact PI
Preclinical development of gene-edited human hematopoietic stem cells$270,000
U19 · FY2017 · HL · contact PI
Preclinical development of gene-edited human hematopoietic stem cells$270,000
U19 · FY2016 · HL · contact PI
Preclinical development of gene-edited human hematopoietic stem cells$287,250
U19 · FY2015 · HL · contact PI